Insider filing · ANIP
Chad Gassert
SVP - CORP. DEV. & STRATEGY
profile →
ANI Pharmaceuticals, Inc.
ANIP · Healthcare · 50 filings in 24 months
ticker →
Chad Gassert sold $1.7M of ANI Pharmaceuticals (ANIP)
Executed Aug 15 2025, disclosed Aug 18 2025, 3 days later.
Value, as filed
$1.7M
20,000 sh × $86.97
Executed
Aug 15 2025
the trade date, as filed
Disclosed
Aug 18 2025
3 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
CGChad Gassert (SVP - CORP. DEV. & STRATEGY) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in ANI Pharmaceuticals, Inc. (ANIP). The largest single filing was $1.3M of ANIP (14,642 sh × $89.07, as filed), executed Nov 12 2025.
The name
ANIPHealthcare · ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Chad Gassert in ANIP
ANIPSALE
ANI Pharmaceuticals, Inc.
$1.3M14,642 sh × $89.07
Exec Nov 12 2025
Filed Nov 14 2025 · 5:30 PM ET